Champions Oncology, Inc.

Biotechnology • Healthcare • Hackensack, NJ, United States • CSBR (NCM)

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Shareholders in Champions Oncology (NASDAQ:CSBR) are in the red if they invested five years ago - Yahoo Finance

Yahoo Finance • Dec 7

Earnings call transcript: Champions Oncology Q2 2025 sees strong revenue growth - Investing.com

Investing.com • Dec 15

Champions Oncology (NASDAQ: CSBR) lifts Q2 revenue 11% to $15M, earns profit - Stock Titan

Stock Titan • Dec 15

Investors in Champions Oncology (NASDAQ:CSBR) from five years ago are still down 41%, even after 11% gain this past week - simplywall.st

simplywall.st • Dec 13

Champions Oncology: Biological IP Is The Real Asset - Not Preclinical Services - Seeking Alpha

Seeking Alpha • Jun 16

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has CHAMPIONS ONCOLOGY, INC. had layoffs?

No layoff events have been recorded for CHAMPIONS ONCOLOGY, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does CHAMPIONS ONCOLOGY, INC. have?

CHAMPIONS ONCOLOGY, INC. has approximately 213 employees.

What industry is CHAMPIONS ONCOLOGY, INC. in?

CHAMPIONS ONCOLOGY, INC. operates in the Biotechnology industry, within the Healthcare sector.

Is CHAMPIONS ONCOLOGY, INC. a publicly traded company?

Yes, CHAMPIONS ONCOLOGY, INC. is publicly traded under the ticker symbol CSBR on the NCM. The company has a market capitalization of approximately $0.10 billion.

Where is CHAMPIONS ONCOLOGY, INC. headquartered?

CHAMPIONS ONCOLOGY, INC. is headquartered in Hackensack, NJ, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.